Ovarian Cancer Proteogenomics Research Award
The summary for the Ovarian Cancer Proteogenomics Research Award grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
Ovarian Cancer Proteogenomics Research Award: The OCRP Proteogenomics Research Award supports the use of proteomics and/or genomics to explore new concepts or theories in ovarian cancer. The award is intended to support the genomic and/or transcriptomic and/or proteomic analysis of currently available clinical specimens with a focus on answering biologic and pathophysiologic questions of clinical relevance in ovarian cancer. The proposed research question should be innovative and have the potential to make an impact on ovarian cancer.Clinical trials are not allowed under the Proteogenomics Research Award mechanism. The analysis of clinical trial-derived specimens and/or large patient specimen cohorts is encouraged. Preliminary data are not required but are allowed.Applicants are encouraged to explore and consider the possible use of the unique proteomics resource at the Women's Health Integrated Research Center Clinical Proteomics Platform, which was established by the Department of Defense (DOD) intramural Gynecologic Cancer Center of Excellence to provide cutting-edge capabilities for identifying and validating protein biomarkers and surrogates for enhanced cancer patient management through improved early detection, patient stratification, and monitoring for therapeutic efficacy, outcomes, and recurrence.
Federal Grant Title: | Ovarian Cancer Proteogenomics Research Award |
Federal Agency Name: | Dept of the Army USAMRAA (DOD-AMRAA) |
Grant Categories: | Science and Technology |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | W81XWH-22-OCRP-PGRA |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 12.420 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | August 5th, 2022 |
Original Application Deadline: | August 5th, 2022 |
Posted Date: | March 18th, 2022 |
Creation Date: | March 18th, 2022 |
Archive Date: | September 4th, 2022 |
Total Program Funding: | $800,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 2 |
Cost Sharing or Matching: | No |
Last Updated: | March 18th, 2022 |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Grant Announcement Contact
- CDMRP Help Desk
Phone: 301-682-5507
Email: [email protected]
CDMRP Help Desk - Similar Government Grants
- • DOD Pancreatic Cancer, Translational Research Partnership Award
- • DOD Pancreatic Cancer, Idea Development Award
- • DOD Pancreatic Cancer, Focused Pilot Award
- • DoD Autism, Discovery Award
- • DoD Tick-Borne Disease, Idea Development Award
- • FY2006 Deployed War Fighter Protection Research Program
- • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
- • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
- • Military Health System Research Program Notice of Funding Opportunity
- • DoD Tick-Borne Disease, Therapeutic/Diagnostic Research Award
- • DoD Rare Cancers, Concept Award